SANDAY BIOSCIENCE LIMITED
Executive Summary
Sanday Bioscience Limited occupies a specialized niche in learned journal publishing, leveraging scientific expertise to establish a foundational market position. Its strategic assets include intellectual capital and financial prudence, though growth hinges on expanding digital capabilities, partnerships, and diversified content offerings. Key risks involve financial constraints, competitive pressures, and operational dependence on a sole director, necessitating proactive investment and governance enhancements to realize sustainable growth.
View Full Analysis Report →Company Documents
Date | Description |
---|---|
08/04/258 April 2025 | Total exemption full accounts made up to 2025-01-31 |
31/01/2531 January 2025 | Annual accounts for year ending 31 Jan 2025 |
20/01/2520 January 2025 | Confirmation statement made on 2025-01-11 with no updates |
10/05/2410 May 2024 | Accounts for a dormant company made up to 2024-01-31 |
31/01/2431 January 2024 | Annual accounts for year ending 31 Jan 2024 |
24/01/2424 January 2024 | Confirmation statement made on 2024-01-11 with no updates |
31/03/2331 March 2023 | Accounts for a dormant company made up to 2023-01-31 |
31/01/2331 January 2023 | Annual accounts for year ending 31 Jan 2023 |
13/01/2313 January 2023 | Confirmation statement made on 2023-01-11 with no updates |
29/09/2229 September 2022 | Accounts for a dormant company made up to 2022-01-31 |
31/01/2231 January 2022 | Annual accounts for year ending 31 Jan 2022 |
24/01/2224 January 2022 | Confirmation statement made on 2022-01-11 with no updates |
12/01/2112 January 2021 | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company